Found: 9
Select item for more details and to access through your institution.
Limitations in Research on Maintenance Treatment for Individuals With Schizophrenia.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Tapering Antipsychotic Treatment.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The risks of adverse events with venlafaxine and mirtazapine versus 'active placebo', placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis.
- Published in:
- Systematic Reviews, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s13643-023-02221-5
- By:
- Publication type:
- Article
Antidepressant Compounds Can Be Both Pro- and Anti-Inflammatory in Human Hippocampal Cells.
- Published in:
- International Journal of Neuropsychopharmacology, 2015, v. 18, n. 3, p. 1
- By:
- Publication type:
- Article
Distinguishing relapse from antidepressant withdrawal: clinical practice and antidepressant discontinuation studies.
- Published in:
- BJPsych Advances, 2022, v. 28, n. 5, p. 297, doi. 10.1192/bja.2021.62
- By:
- Publication type:
- Article
Risks and Benefits of Benzodiazepines.
- Published in:
- 2021
- By:
- Publication type:
- letter
Confounding of Antipsychotic Discontinuation Studies by Withdrawal-Related Relapse.
- Published in:
- Schizophrenia Bulletin, 2022, v. 48, n. 2, p. 294, doi. 10.1093/schbul/sbab146
- By:
- Publication type:
- Article
A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse.
- Published in:
- Schizophrenia Bulletin, 2021, v. 47, n. 4, p. 1116, doi. 10.1093/schbul/sbab017
- By:
- Publication type:
- Article
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data.
- Published in:
- CNS Drugs, 2023, v. 37, n. 2, p. 143, doi. 10.1007/s40263-022-00960-y
- By:
- Publication type:
- Article